Literature DB >> 7948096

Preparation of asialoorosomucoid-polylysine conjugates.

T D McKee1, M E DeRome, G Y Wu, M A Findeis.   

Abstract

Asialoorosomucoid-polylysine (ASOR-PL) conjugates have been recently developed as carriers of electrostatically bound DNA for targeted delivery to the hepatic asialoglycoprotein receptor (ASGPr) for gene therapy. Using acid-urea gel electrophoresis we have found that previously reported procedures for the fractionation of ASOR-PL conjugates do not efficiently remove noncovalently bound polylysine (PL) from ASOR-PL. DNA complexes prepared with these conjugates have low solubilities, which limits their usefulness for subsequent experimentation, particularly in vivo. For ASOR-PL made by carbodiimide-mediated crosslinking with 5-kDa PL, dialysis against 1 M guanidine hydrochloride is effective to remove the low molecular weight unbound PL. Dialysis is not feasible when using higher molecular weight PLs, but preparative elution acid-urea gel electrophoresis was used to isolate crude ASOR-PL fractions free of unbound PL. ASOR-PL freed of PL by dialysis or electrophoresis was further fractionated by cation-exchange HPLC on carboxymethyl-functionalized columns eluted with a mixed pH-salt gradient. Early-eluting ASOR-PL fractions isolated by a combination of preparative elution acid-urea gel electrophoresis and cation-exchange HPLC were found to be preferred for the formation of soluble DNA complexes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948096     DOI: 10.1021/bc00028a004

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  5 in total

1.  A DNA delivery system containing listeriolysin O results in enhanced hepatocyte-directed gene expression.

Authors:  Cherie M Walton; Catherine H Wu; George Y Wu
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  DNA condensation for gene therapy as monitored by atomic force microscopy.

Authors:  H G Hansma; R Golan; W Hsieh; C P Lollo; P Mullen-Ley; D Kwoh
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

3.  PEG-Peptide Inhibition of Scavenger Receptor Uptake of Nanoparticles by the Liver.

Authors:  Rondine J Allen; Basil Mathew; Kevin G Rice
Journal:  Mol Pharm       Date:  2018-08-13       Impact factor: 4.939

Review 4.  Glycotargeting to improve cellular delivery efficiency of nucleic acids.

Authors:  Hongbin Yan; Kha Tram
Journal:  Glycoconj J       Date:  2007-02-01       Impact factor: 2.916

5.  Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers.

Authors:  H C Chiou; M V Tangco; S M Levine; D Robertson; K Kormis; C H Wu; G Y Wu
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.